US wants coronavirus vaccine patent waiver to benefit world, not boost China biotech


Source: businessinsider.com businessinsider.com

Key Topics in this News Article:

News Snapshot:

Korea Times May. 9, 2021, 03:07 AM The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to aid poor countries will not hand sensitive U.S. biopharmaceutical technology to China and Russia, responding to a chorus of concerns, U.S. and industry officials say.